SCHEMBL30927008

SCHEMBL30927008

CCCNC(=O)CN(CCC)C(=O)c1cccc(S(=O)(=O)Nc2ccc(Br)cc2)c1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.52
▸ KMT2A Q03164 4/20 0.52
▸ ADORA3 P0DMS8 1/20 0.52
▸ SLC6A3 Q01959 1/20 0.52
▸ PKM P14618 3/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ LIMK1 P53667 1/20 0.45
▸ MAPT P10636 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ LMNA P02545 1/20 0.44
▸ ALOX12 P18054 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ BRD4 O60885 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ PGR P06401 1/20 0.43
▸ UBE2N P61088 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27180747 1.00 MEN1 (0.52) MEN1KMT2AADORA3SLC6A3PKM
SCHEMBL30926954 0.82 MEN1 (0.64) MEN1KMT2AADORA3SLC6A3PKM
SCHEMBL27179907 0.82 MEN1 (0.64) MEN1KMT2AADORA3SLC6A3PKM
SCHEMBL27362361 0.80 L3MBTL1 (0.40) MEN1KMT2AADORA3SLC6A3PKM
SCHEMBL27179721 0.77 MEN1 (0.68) MEN1KMT2AADORA3SLC6A3PKM
SCHEMBL30926666 0.77 MEN1 (0.68) MEN1KMT2AADORA3SLC6A3PKM
SCHEMBL27180940 0.74 KMT2A (0.73) MEN1KMT2AADORA3SLC6A3PKM
SCHEMBL30926677 0.74 KMT2A (0.73) MEN1KMT2AADORA3SLC6A3PKM
SCHEMBL30926985 0.73 MEN1 (0.62) MEN1KMT2AADORA3SLC6A3PKM
SCHEMBL27180718 0.73 MEN1 (0.62) MEN1KMT2AADORA3SLC6A3PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP MEN1 4795/4885KMT2A 2544/4885ADORA3 2677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback